Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Penumbra IncPEN · Entity 3430 | Director | February 13, 2026 | February 19, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Penumbra Inc
Report date February 13, 2026 · Filed February 19, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 1,147 |
Reported balance
After 2026-02-13 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-02-13 · Grant · Acquired 589 · Balance 1,147 F1: Restricted stock units (RSUs) vest as to 1/4 on each of March 31, 2026, June 30, 2026, September 30, 2026, and December 31, 2026, subject to Dr. Bose's continued service as director through such dates. Notwithstanding the foregoing, if the Closing (as defined in that certain Agreement and Plan of Merger, dated as of January 14, 2026, among the Issuer, Boston Scientific Corporation, a Delaware corporation, and Pinehurst Merger Sub, Inc., a Delaware corporation) occurs, any of the RSUs that remain unvested will fully vest on the Closing, subject to Dr. Bose's continued service as director through such date. F2: A portion of these shares is subject to vesting. |
| Common StockSEC Table I · non-derivative | IndirectBy LLC | 258,462 |
Reported balance
Holding disclosure · report date 2026-02-13 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 258,462 F3: Shares are held by Bose Family Holdings II, LLC. |
Filing footnotes · ownership attribution and instrument terms
F1: Restricted stock units (RSUs) vest as to 1/4 on each of March 31, 2026, June 30, 2026, September 30, 2026, and December 31, 2026, subject to Dr. Bose's continued service as director through such dates. Notwithstanding the foregoing, if the Closing (as defined in that certain Agreement and Plan of Merger, dated as of January 14, 2026, among the Issuer, Boston Scientific Corporation, a Delaware corporation, and Pinehurst Merger Sub, Inc., a Delaware corporation) occurs, any of the RSUs that remain unvested will fully vest on the Closing, subject to Dr. Bose's continued service as director through such date.
F2: A portion of these shares is subject to vesting.
F3: Shares are held by Bose Family Holdings II, LLC.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 06, 2016 Filed Sep 7, 2016 01:13 UTC | Penumbra Inc PEN · Entity 3430 | SaleCommon Stock | 24,656 | $71.23 | $1,756,246.88 |
DisclosureSEC source: 0001321732-16-000067 · wf-form4_147321082555868.xml · nonDerivative · entry 8 Bose Arani · CIK 0001651318 · Director · Chief Innovator 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 732,191 F1 · kind: The sales were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan. F6 · price: This transaction was executed in multiple trades at prices ranging from $71.04 to $71.37. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| September 06, 2016 Filed Sep 7, 2016 01:13 UTC | Penumbra Inc PEN · Entity 3430 | SaleCommon Stock | 10,344 | $70.81 | $732,458.64 |
DisclosureSEC source: 0001321732-16-000067 · wf-form4_147321082555868.xml · nonDerivative · entry 7 Bose Arani · CIK 0001651318 · Director · Chief Innovator 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 756,847 F1 · kind: The sales were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan. F5 · price: This transaction was executed in multiple trades at prices ranging from $70.04 to $71.03. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| September 06, 2016 Filed Sep 7, 2016 01:13 UTC | Penumbra Inc PEN · Entity 3430 | Exercise / conversionCommon Stock | 35,000 | $1.26 | $44,100.00 |
DisclosureSEC source: 0001321732-16-000067 · wf-form4_147321082555868.xml · nonDerivative · entry 6 Bose Arani · CIK 0001651318 · Director · Chief Innovator 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 767,191 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 02, 2016 Filed Sep 7, 2016 01:13 UTC | Penumbra Inc PEN · Entity 3430 | Exercise / conversionStock Option (right to buy) · Derivative | 15,300 | $0.00 Strike: $1.26 | $0.00 |
DisclosureSEC source: 0001321732-16-000067 · wf-form4_147321082555868.xml · derivative · entry 12 Bose Arani · CIK 0001651318 · Director · Chief Innovator 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 92,200 Underlying: Common Stock · 15,300 shares Expires 2017-04-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F9 · derivative.exercise_date: All shares are vested and exercisable. Read SEC document |
| September 02, 2016 Filed Sep 7, 2016 01:13 UTC | Penumbra Inc PEN · Entity 3430 | SaleCommon Stock | 15,300 | $70.42 | $1,077,426.00 |
DisclosureSEC source: 0001321732-16-000067 · wf-form4_147321082555868.xml · nonDerivative · entry 5 Bose Arani · CIK 0001651318 · Director · Chief Innovator 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 732,191 F1 · kind: The sales were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan. F4 · price: This transaction was executed in multiple trades at prices ranging from $69.97 to $70.68. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| September 02, 2016 Filed Sep 7, 2016 01:13 UTC | Penumbra Inc PEN · Entity 3430 | Exercise / conversionCommon Stock | 15,300 | $1.26 | $19,278.00 |
DisclosureSEC source: 0001321732-16-000067 · wf-form4_147321082555868.xml · nonDerivative · entry 4 Bose Arani · CIK 0001651318 · Director · Chief Innovator 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 747,491 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 01, 2016 Filed Sep 7, 2016 01:13 UTC | Penumbra Inc PEN · Entity 3430 | Exercise / conversionStock Option (right to buy) · Derivative | 10,700 | $0.00 Strike: $1.26 | $0.00 |
DisclosureSEC source: 0001321732-16-000067 · wf-form4_147321082555868.xml · derivative · entry 11 Bose Arani · CIK 0001651318 · Director · Chief Innovator 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 107,500 Underlying: Common Stock · 10,700 shares Expires 2017-04-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F9 · derivative.exercise_date: All shares are vested and exercisable. Read SEC document |
| September 01, 2016 Filed Sep 7, 2016 01:13 UTC | Penumbra Inc PEN · Entity 3430 | SaleCommon Stock | 700 | $70.24 | $49,168.00 |
DisclosureSEC source: 0001321732-16-000067 · wf-form4_147321082555868.xml · nonDerivative · entry 3 Bose Arani · CIK 0001651318 · Director · Chief Innovator 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 732,191 F1 · kind: The sales were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan. F3 · price: This transaction was executed in multiple trades at prices ranging from $70.22 to $70.25. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| September 01, 2016 Filed Sep 7, 2016 01:13 UTC | Penumbra Inc PEN · Entity 3430 | SaleCommon Stock | 10,000 | $69.84 | $698,400.00 |
DisclosureSEC source: 0001321732-16-000067 · wf-form4_147321082555868.xml · nonDerivative · entry 2 Bose Arani · CIK 0001651318 · Director · Chief Innovator 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 732,891 F1 · kind: The sales were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan. F2 · price: This transaction was executed in multiple trades at prices ranging from $69.21 to $70.20. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| September 01, 2016 Filed Sep 7, 2016 01:13 UTC | Penumbra Inc PEN · Entity 3430 | Exercise / conversionCommon Stock | 10,700 | $1.26 | $13,482.00 |
DisclosureSEC source: 0001321732-16-000067 · wf-form4_147321082555868.xml · nonDerivative · entry 1 Bose Arani · CIK 0001651318 · Director · Chief Innovator 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 742,891 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.